STOCK TITAN

Churchill Capital Corp XII Units 8-K Filings

CXIIU NASDAQ

Every 8-K that Churchill Capital Corp XII Units (CXIIU) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow CXIIU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CXIIU filings page.

Rhea-AI Summary

Churchill Capital Corp XII appointed Paul D. Lapping as a director on July 13, 2026, effective immediately. He joins the compensation committee and the audit committee and becomes chairperson of the Audit Committee, replacing William Sherman as interim chair; Mr. Sherman will remain an Audit Committee member. Lapping will serve in the first class of directors, with his term expiring at the company’s first annual general meeting.

Lapping, age 63, manages Jakal Investments, LLC, which he founded in 2005, and Green Pastures Management, LLC, and has extensive SPAC board and executive experience. He signed a joinder to an April 27, 2026 letter agreement to waive certain redemption rights and vote any of his ordinary shares in favor of an initial business combination, and entered into a standard director indemnity agreement. On July 14, 2026, the company executed director agreements with Lapping and William Sherman, providing each with $75,000 per annum in cash compensation beginning August 1, 2026.

Rhea-AI Summary

Churchill Capital Corp XII is allowing its securities to trade separately instead of only as bundled units. Starting June 17, 2026, investors who hold units from the company’s initial public offering can ask their brokers to split them into individual Class A ordinary shares and redeemable warrants.

Each unit currently consists of one Class A ordinary share with a par value of $0.0001 and one-tenth of one redeemable warrant. Each whole warrant allows the holder to buy one Class A ordinary share at an exercise price of $11.50 per share. After separation, unsplit units will keep trading on Nasdaq under the symbol CXIIU, while the Class A shares and warrants will trade under CXII and CXIIW, respectively.

Rhea-AI Summary

Churchill Capital Corp XII completed its initial public offering of 41,400,000 units at $10.00 each, raising $414,000,000 in gross proceeds. Each unit contains one Class A ordinary share and one-tenth of a redeemable warrant, with each whole warrant exercisable at $11.50 per share.

The sponsor simultaneously purchased 350,000 private placement units for $3,500,000. A total of $414,000,000, or $10.00 per public unit, was placed in a U.S. trust account, while $726,445 of cash remained outside the trust and working capital was $1,012,122 as of April 29, 2026.

The SPAC has 41,400,000 Class A shares classified as redeemable at $10.00 per share and 13,800,000 Class B founder shares outstanding. It has up to 24 months, or 27 months under specified conditions, to complete an initial business combination before redeeming public shares and liquidating.

Rhea-AI Summary

Churchill Capital Corp XII completed an upsized initial public offering of 41,400,000 units at $10.00 per unit, generating gross proceeds of $414,000,000. Each unit includes one Class A ordinary share and one-tenth of a redeemable warrant, with each whole warrant exercisable at $11.50 per share.

The company also sold 350,000 private placement units to its sponsor for $3,500,000. A total of $414,000,000 from the IPO and private placement was deposited into a U.S. trust account, generally locked until a future business combination or required redemptions within 24 to 27 months.

In connection with the IPO, the company adopted amended and restated governing documents, entered multiple key agreements, and appointed William Sherman to the board, including roles on the Audit and Compensation Committees, while executing broad indemnification protections for directors and officers.